U.S. Acute Respiratory Distress Syndrome (ARDS) Market is Expected to Grow at 10.6% in the Forecast Period of 2022 to 2029

U.S. Acute Respiratory Distress Syndrome (ARDS) Market is growing due to increasing prevalence and acute lung injury diseases. Increasing COVID-19 infection which is associated with ARDS is also propelling the growth of the U.S. ARDS market.

However, the high cost of treatment may hamper the growth of the market.

U.S. Acute Respiratory Distress Syndrome (ARDS) Market Scenario

According to Data Bridge Market Research, the market for U.S. acute respiratory distress syndrome (ARDS) market in the U.S. has the highest market share. Market leader is Gilead Sciences, Inc. which accounts an estimated market share of approximately 60% to 70%. The company has gained outstanding sales through providing healthcare devices and different medicines.

  • In July 2020, Gilead Sciences Inc. initiated clinical testing of an inhaled solution of Remdesivir for potential outpatient treatment of COVID-19. This testing helped the company enhance its antiviral product portfolio, thereby strengthening its footprints over the market.

U.S. Acute Respiratory Distress Syndrome (ARDS) MarketTrends Impacting the Market

The U.S. acute respiratory distress syndrome (ARDS) market is becoming more competitive with companies such as Gilead Sciences, Inc., Terumo Corporation, and Getinge AB as they are the market leaders for acute respiratory distress syndrome (ARDS). The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the acute respiratory distress syndrome (ARDS) market.

For More Analysis on the U.S. Acute Respiratory Distress Syndrome (ARDS) Market Request for a Briefing with our Analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=us-acute-respiratory-distress-syndrome-ards-market

U.S. Acute Respiratory Distress Syndrome (ARDS) Market Development

  • In April 2020, Terumo Corporation has doubled the extracorporeal membrane oxygenation ECMO Production and Supply. ECMO consists of an oxygenator and centrifugal pump which is used for the patients with severe respiratory failure. This will help company to increase its market growth in the market.

Scope of the U.S. Acute Respiratory Distress Syndrome (ARDS) Market

All country based analysis of the U.S. acute respiratory distress syndrome (ARDS) market is further analysed based on maximum granularity into further segmentation. Based on the cause, the acute respiratory distress syndrome (ARDS) market is segmented into coronavirus disease 2019 (COVID-19), sepsis, inhalation of harmful substances, severe pneumonia, and others. Based on type, the acute respiratory distress syndrome (ARDS) market is segmented into diagnosis and treatment. Based on route of administration, the acute respiratory distress syndrome (ARDS) market is segmented into oral, parenteral, and others. Based on end user, the acute respiratory distress syndrome (ARDS) market is segmented into hospitals, specialty clinics, home healthcare and others. Based on distribution channel, the acute respiratory distress syndrome (ARDS) market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others.

To Know More about this Study https://www.databridgemarketresearch.com/reports/us-acute-respiratory-distress-syndrome-ards-market

Key Pointers Covered in U.S. Acute Respiratory Distress Syndrome (ARDS) Market Industry Trends and Forecast to 2029

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Market value and over view of acute respiratory distress syndrome (ARDS) market
  • Company profiling of top eight players of acute respiratory distress syndrome (ARDS) market

Key Market Competitors Covered in the Report

The key market players for U.S. acute respiratory distress syndrome (ARDS) market are listed below:

  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare, Limited.
  • LivaNova PLC
  • Gilead Sciences, Inc.
  • Fresenius SE & Co. KGaA
  • Armstrong Medical
  • Smiths Medical
  • ResMed
  • ALung Technologies, Inc.
  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • Hamilton Medical
  • nice Neotech Medical Systems Pvt. Ltd.
  • Pfizer Inc.
  • WEINMANN Emergency Medical Technology GmbH + Co. KG, NIPRO
  • Terumo Medical Corporation
  • Getinge AB.
  • EUROSETS

Above are the Key Players Covered in the Report, to know About more and Exhaustive list of U.S. Acute Respiratory Distress Syndrome (ARDS) Companies, Contact us https://www.databridgemarketresearch.com/toc/?dbmr=us-acute-respiratory-distress-syndrome-ards-market

Research Methodology: U.S. Acute Respiratory Distress Syndrome (ARDS) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Clinicians, Healthcare Professionals, Researchers, Academician.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/